ArticleVaccines2022

Frequency and Nuisance Level of Adverse Events in Individuals Receiving Homologous and Heterologous COVID-19 Booster Vaccine.

Piotr Rzymski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.